We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Events

05 Aug 2026 - 07 Aug 2026
18 Aug 2026 - 20 Aug 2026

Connected Dose Inhaler Optimizes Respiratory Care

By HospiMedica International staff writers
Posted on 27 Dec 2016
A novel embedded metered dose inhaler (eMDI) enables improved adherence and real-time monitoring of asthma and chronic obstructive pulmonary disorder (COPD) patients.

The H&T Presspart (Blackburn, United Kingdom) eMDI is an intuitive, connected eMDI that tracks, records, and shares data on both preventive and relief medications, thus empowering patients in their self-care and improving adherence. More...
The connected data also aids real-time monitoring of medication use and symptom flare-ups by caregivers. Sensors within the inhaler track the date and time of medication use as well as the quality of delivery, which is recorded in onboard memory and also shared wirelessly Bluetooth, syncing with the BreatheSmart app.

The BreatheSmart app can thus provide users and caregivers customized reminders, real-time alerts and updates on medication usage, weekly and monthly summary reports which can be shared with family, caregivers and/or healthcare providers, and secure, automatic, realtime electronic medical record (EMR) integration. The medication utilization data from the eMDI can be merged with lung function data from the Cohero Health (New York, NY, USA) mSpirometer, a clinical grade handheld wireless spirometer that precisely measures critical lung function metrics.

Features of the device include embedded sensors to detect medication use and quality of medication administration, an embedded mechanical or electronic dose count and an intuitive and discrete design. Operation is consistent with standard puffer MDI operation, and is compatible with any canister. Battery life is consistent with the product shelf life, meaning that there is no need for replacement parts and no recharging or battery changes. In addition, the device incorporates a mechanical dose counter to allow pharmaceutical companies to transition current products to connected devices more easily.

“In designing the eMDI, our mission was to help pharmaceutical companies bring the best possible care to patients in an intuitive device in the fastest time and most cost-efficient way,” said Peter Schmelzer, CEO of H&T Presspart.

“We have thus combined the design of the world’s most widely used and established inhaler technology with the only respiratory platform that gives a complete and objective picture of how a patient is responding to treatment between reviews,” said Mellissa Manice, co-founder and CEO of Cohero Health.

Related Links:
H&T Presspart
Cohero Health

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Biochip Array Technology
Evidence MultiSTAT Drugs of Abuse Urine Multiplex Panel
New
Radiology Monitor
Barco MDNC-12130 Nio Fusion 12MP Radiology Monitor
POC Respiratory/Sore Throat Test
BIOFIRE SPOTFIRE (R/ST) Panel
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Copyright © 2000-2026 Globetech Media. All rights reserved.